1. ADDI Medical
  2. /
  3. Platform building blocks
  4. /
  5. Clinical decision support
  Dela sida:

Clinical decision support

HOPE Platform offers diagnosis-specific clinical decision support. This means that, each diagnostic area identifies the advice and recommendations required by healthcare staff and the patient the form of prevention, prognosis, diagnostics, treatment and follow-up.

The information registered by the patient is used to highlight the patient or patients that require prioritisation for patient-specific advice.

If required, patient-specific advice can be configured quickly, easily and securely using the Automation building block.



The clinical decision support for Psoriasis indicates and directs the attention of healthcare staff when: a) a Psoriasis Area and Severity Index (PASI) score is above 3; b) a Dermatology Life Quality Index (DLQI) score is above 5; c) when the most recent PASI or DLQI was recorded more than 6 months ago; and d) when PASI or DLQI is missing for a patient.

Within the diagnostic area of Psoriasis, two evidence-based medical screening protocols are used: DLQI, which is a questionnaire used to measure the effects of dermatological diseases on a patient’s quality of life and PASI, which is the most widely used tool for measuring the severity of psoriasis.

HOPE Platform has implemented both the PASI and the DLQI algorithms and the calculation service automatically calculates scores as soon as a new form is saved.


The clinical decision support for Obesity indicates and directs the attention of healthcare staff when the patient: a) has had a 10% weight change in 3 months (up or down); b) has not registered a weight measurement for 1 month; c) has not recorded steps for 2 weeks; d) completed the last visit more than 3 months ago; and e) has a BMI/SDS that exceeds the limit set by staff.

Within the diagnostic area of Obesity, a BMI/SDS value is used to measure the severity of obesity.

The calculation service calculates the BMI/SDS value in the HOPE Platform.


The clinical decision support for the ROP (retinopathy of prematurity) disease of the eye indicates and directs the attention of healthcare staff when the patient: a) has an ROP score above 4; b) the guardian has missed a screening visit; c) the child has been moved to another hospital and dialogue between the hospitals is needed to assess possible treatment and/or intervention.

ROP is a consequence of premature birth and occurs in the form of an injury to the eye caused by abnormal growth of blood vessels, causing scarring on the retina or retinal detachment. Like several other types of disease, ROP is graded on a scale using a screening protocol that ranges from zero to twenty, where twenty is the most severe and zero means there is no impact at all.

Healthcare staff use an evidence-based screening protocol for ROP in its assessment .

HOPE Platform has implemented ROP scoring and the calculation service performs calculation of the score. The score is made available to guardian(s) via HOPE App.


Vill du veta mer om våra lösningar?

Fyll i din e-post och/eller telefonnummer så hör vi av oss inom kort!